Atripla and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate), especially for people who are male, 30-39 old, have been taking the drug for 1 - 2 years also take Truvada, and have Seizures.

The phase IV clinical study analyzes which people have Drowsiness when taking Atripla. It is created by eHealthMe based on reports of 35,479 people who have side effects when taking Atripla from the FDA, and is updated regularly.

What is Atripla?

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.

What is Drowsiness?

Drowsiness is found to be associated with 2,876 drugs and 4,757 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Oct, 12, 2025

35,479 people reported to have side effects when taking Atripla.
Among them, 108 people (0.3%) have Drowsiness.

Among these 108 people:

How long have people been on Atripla when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Atripla? *

female: 23.58 %
male: 76.42 %

What is the age of people who have Drowsiness when taking Atripla? *

What are other drugs people take besides Atripla? *

What are other side effects people have besides Drowsiness? *

Stress And Anxiety: 17 people, 15.74%
Abnormal Dreams: 17 people, 15.74%
Pain: 17 people, 15.74%
Emotional Distress: 16 people, 14.81%
Fatigue (feeling of tiredness): 15 people, 13.89%
Drug Ineffective: 15 people, 13.89%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 15 people, 13.89%
Depression: 13 people, 12.04%
Bone Density Decreased: 12 people, 11.11%
Chronic Kidney Disease: 11 people, 10.19%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 9.26%
Hepatitis C: 3 people, 2.78%
Quit Smoking: 2 people, 1.85%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 1 person, 0.93%
Hiv Test Positive: 1 person, 0.93%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 0.93%
Depression: 1 person, 0.93%
Dry Eyes (lack of adequate tears): 1 person, 0.93%
Dry Skin: 1 person, 0.93%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 0.93%

* Approximation only. Some reports may have incomplete information.

Do you take Atripla and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atripla:

Atripla (36,036 reports)

Drowsiness treatments and more:

Drowsiness (269,039 reports)

How severe was Drowsiness and when was it recovered:

Drowsiness in Atripla

Expand to all the drugs that have ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate:

Drowsiness and drugs with ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Common Atripla side effects:

Browse all side effects of Atripla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Drowsiness:

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,876 drugs)

Common conditions associated with Drowsiness:

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,757 conditions)

Drugs similar to Atripla and Drowsiness :

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Atripla) and Atripla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.